Roche Polymerase Inhibitor Shows Promise In Phase II
This article was originally published in The Pink Sheet Daily
Executive Summary
Ahead of AASLD, Roche’s Senior Medical Director Thommes discusses the firm’s hepatitis C pipeline with “The Pink Sheet” DAILY.